NVAX (Novavax Inc)
Insider Trading Activity
Every open-market purchase and sale reported by NVAX officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-23 | Charles W. Newton | Director | A | — | — |
| 2026-06-23 | Richard J Rodgers | Director | M | — | — |
| 2026-06-23 | DAVID M MOTT | Director | M | — | — |
| 2026-06-23 | RICHARD DOUGLAS | Director | M | — | — |
| 2026-06-23 | Rachel K. King | Director | M | — | — |
| 2026-06-23 | MARGARET G MCGLYNN | Director | M | — | — |
| 2026-06-23 | John W. Shiver | Director | A | — | — |
| 2026-06-23 | Gregg H Alton | Director | M | — | — |
| 2026-04-28 | Charles W. Newton | Director | M | — | — |
| 2026-04-16 | Robert Edward Walker | EVP, R&D | A | — | — |
| 2026-03-12 | John W. Shiver | Director | M | — | — |
| 2026-03-09 | Mark J Casey | EVP, Chief Legal Officer | A | — | — |
| 2026-03-09 | Ruxandra Draghia-Akli | EVP, Research & Development | A | — | — |
| 2026-03-09 | James Patrick Kelly | EVP, CFO and Treasurer | A | — | — |
| 2026-03-09 | Elaine O'Hara | EVP, Chief Strategy Officer | A | — | — |
| 2026-03-09 | John C Jacobs | President and CEO | A | — | — |
| 2026-03-09 | James Patrick Kelly | EVP, CFO and Treasurer | MIXED | — | — |
| 2026-03-05 | John C Jacobs | President and CEO | MIXED | — | — |
| 2026-03-05 | Elaine O'Hara | EVP, Chief Strategy Officer | MIXED | — | — |
| 2026-03-05 | James Patrick Kelly | EVP, CFO and Treasurer | MIXED | — | — |
| 2026-03-05 | Mark J Casey | EVP, Chief Legal Officer | MIXED | — | — |
| 2026-03-05 | Ruxandra Draghia-Akli | EVP, Research & Development | MIXED | — | — |
| 2026-03-03 | Elaine O'Hara | EVP, Chief Strategy Officer | MIXED | — | — |
| 2026-03-03 | John C Jacobs | President and CEO | MIXED | — | — |
| 2026-03-03 | Mark J Casey | EVP, Chief Legal Officer | MIXED | — | — |
| 2026-03-03 | James Patrick Kelly | EVP, CFO and Treasurer | MIXED | — | — |
| 2026-01-26 | John C Jacobs | President and CEO | MIXED | — | — |
| 2025-12-15 | Mark J Casey | EVP, Chief Legal Officer | MIXED | — | — |
| 2025-11-13 | Ruxandra Draghia-Akli | Section 16 | MIXED | — | — |
| 2025-10-30 | Richard J Rodgers | Director | M | — | — |
| 2025-06-24 | MARGARET G MCGLYNN | Director | A | — | — |
| 2025-06-24 | RICHARD DOUGLAS | Director | A | — | — |
| 2025-06-24 | Gregg H Alton | Director | A | — | — |
| 2025-06-24 | DAVID M MOTT | Director | A | — | — |
| 2025-06-24 | Richard J Rodgers | Director | A | — | — |
| 2025-06-24 | Rachel K. King | Director | A | — | — |
| 2025-06-16 | Gregg H Alton | Director | M | — | — |
| 2025-06-16 | MARGARET G MCGLYNN | Director | M | — | — |
| 2025-06-13 | Rachel K. King | Director | M | — | — |
| 2025-06-13 | DAVID M MOTT | Director | M | — | — |
| 2025-06-13 | RICHARD DOUGLAS | Director | M | — | — |
| 2025-06-13 | Richard J Rodgers | Director | M | — | — |
| 2025-04-29 | Charles W. Newton | Director | A | — | — |
| 2025-03-12 | John W. Shiver | Director | A | — | — |
| 2025-03-11 | John Trizzino | President and COO | MIXED | — | — |
| 2025-03-11 | James Patrick Kelly | EVP, CFO and Treasurer | MIXED | — | — |
| 2025-03-05 | Ruxandra Draghia-Akli | Section 16 | A | — | — |
| 2025-03-05 | John C Jacobs | President and CEO | A | — | — |
| 2025-03-05 | James Patrick Kelly | EVP, CFO and Treasurer | A | — | — |
| 2025-03-05 | Mark J Casey | EVP, Chief Legal Officer | A | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | 10%+ Owner | 575,000 | — |
| — | President and CEO | 225,680 | — |
| — | Director | 161,268 | — |
| — | Director | 157,591 | — |
| — | EVP, Chief Strategy Officer | 134,642 | — |
| — | EVP, CFO and Treasurer | 130,599 | — |
| — | Director | 125,000 | — |
| — | EVP, Chief Legal Officer | 90,067 | — |
| — | President and COO | 82,015 | — |
| — | Director | 79,770 | — |
| — | Director | 73,220 | — |
| — | President, R&D | 66,613 | — |
| — | Director | 58,660 | — |
| — | Director | 47,685 | — |
| — | Director | 47,370 | — |
| — | Director | 45,170 | — |
| — | Director | 44,468 | — |
| — | President and CEO | 36,492 | — |
| — | EVP, Research & Development | 23,563 | — |
| — | Director | 19,549 | — |
| — | President, R&D | 18,339 | — |
| — | EVP, Chief Legal Officer | 17,317 | — |
| — | Director | 10,101 | — |
| — | Director | 10,000 | — |
| — | President, CEO | 9,742 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the NVAX quote page; the site-wide leaderboard is on the insider transactions hub.